Chongqing Huapont Pharm. Co., Ltd. ( China (Mainland))

Huapont is a pharmaceutical company which mainly manufactures and markets Active Pharmaceutical Ingredients (APIs) as well as finished dosages to the domestic and international market. In additioh, Huapont also offers a wide range of products and services to companies involved in pharmaceutical, veterinary, nutraceutical, cosmetic, specialty chemicals, and other industries.

Hanjiang Pharmaceutical is an US-cGMP compliant pharmaceutical enterprise. This company is not only COS acquired for several products, but also US-FDA inspected and approved. In 2005, Huapont acquired Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. (hereinafter called "Hanjiang Pharmaceutical" ), and takes it as the API exporting base. 

The company provides over 56% market share of China retinoic acids market by value. Other commercial products include Tretinoin (302-79-4), Desonide (638-94-8), Calcipotriol (112965-21-6), Anastrozole (120511-73-1), Pasiniazid (2066-89-9), etc.